These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9694774)

  • 21. [A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden].
    Kolbach DN; Boer J
    Ned Tijdschr Geneeskd; 1998 Dec; 142(49):2706-7. PubMed ID: 10094656
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
    van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
    Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary prophylaxis with warfarin for recurrent thrombosis in a patient with Glanzmann thrombasthenia and F5 G1691A.
    Rezende SM
    Br J Haematol; 2012 Jan; 156(1):144. PubMed ID: 21848888
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
    Robison NJ; Dawlabani N; Lastra CR; Dhall G
    Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple phlebothrombosis following cesarean section due to heterozygous factor V Leiden mutation detected post partum].
    Grulich D; Schulze G; Riedel HH
    Zentralbl Gynakol; 1999; 121(11):526-9. PubMed ID: 10612220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.
    Kahn SR; Kearon C; Julian JA; Mackinnon B; Kovacs MJ; Wells P; Crowther MA; Anderson DR; Van Nguyen P; Demers C; Solymoss S; Kassis J; Geerts W; Rodger M; Hambleton J; Ginsberg JS;
    J Thromb Haemost; 2005 Apr; 3(4):718-23. PubMed ID: 15733061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report.
    Orlandi G; Pellegrinetti A; Fioretti C; Martini A; Murri L
    Angiology; 1998 Jan; 49(1):79-82. PubMed ID: 9456169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perioperative management of a patient with factor V Leiden mutation].
    Kotaka M; Kohchi A
    Masui; 2003 Apr; 52(4):409-11. PubMed ID: 12728494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
    Monastiri K; Seket B; Chouchane S; Samama MM; Mahjoub T
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):138-40. PubMed ID: 16448739
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual complications of warfarin therapy: skin necrosis and priapism.
    Zimbelman J; Lefkowitz J; Schaeffer C; Hays T; Manco-Johnson M; Manhalter C; Nuss R
    J Pediatr; 2000 Aug; 137(2):266-8. PubMed ID: 10931425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary arterial thromboembolism and thrombophilias: optimization of diagnostics and treatment].
    Nikitin AV; Ipatov PV; Fursov AN; Kolebaev DV
    Klin Med (Mosk); 2006; 84(6):21-4. PubMed ID: 16875063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
    Martinelli I; Battaglioli T; De Stefano V; Tormene D; Valdrè L; Grandone E; Tosetto A; Mannucci PM;
    J Thromb Haemost; 2008 Mar; 6(3):494-8. PubMed ID: 18182035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of mortality and the factor V Leiden mutation in a population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    Thromb Haemost; 1998 Oct; 80(4):607-9. PubMed ID: 9798979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden.
    Tan HP; Markowitz JS; Maley WR; Merritt WT; Klein AS
    Liver Transpl; 2000 Sep; 6(5):654-6. PubMed ID: 10980068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.